Quality of hypertension treatment and risk of stroke in the general population

Journal of Hypertension

Volumn 20, Issue 10, 2002, Pages 1949-1950

  Klungel, Olaf H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE CONTROL; HUMAN; HYPERTENSION; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DISEASE MANAGEMENT; DRUG EFFECT; EUROPE; EVIDENCE BASED MEDICINE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; UNITED STATES;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DISEASE MANAGEMENT; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; RISK FACTORS; UNITED STATES;

EID: 0036807589     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200210000-00012     Document Type: Note

References (18)

1. Wilber JA, Barrow JG. Hypertension - A community problem. Am J Med 1972; 52:653-663.
2. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid? J Hum Hypertens 1997; 11:213-220.
3. Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens 1997; 15:237-244.
4. Klungel OH, de Boer A, Paes AH, Nagelkerke NJ, Seidell JC, Bakker A. Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol 2000; 53:1158-1163.
5. Klungel OH, de Boer A, Paes AH, Nagelkerke NJ, Seidell JC, Bakker A. Influence of correction for within-person variability in blood pressure on the prevalence, awareness, treatment, and control of hypertension. Am J Hypertens 2000; 13:88-91.
6. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999; 17:151-183.
7. Joint National Committee on the Prevention D, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
8. Klungel OH, de Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A. Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens 1998; 16:1371-1378.
9. Weinehall L, Öhgren B, Persson M, Stegmayr B, Boman K, Hallmans G, Lindholm LH. High remaining risk in poorly treated hypertension: The rule of halves still exists. J Hypertens 2002; 20:2081 -2088.
10. Klungel OH, Kaplan RC, Heckbert SR, Smith NL, Lemaitre RN, Long-streth WT Jr, et al. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31: 420-424.
11. Klungel OH, Stricker BH, Paes AHP, Seidell JC, Bakker A, Voko Z, et al. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999; 30:1312-1318.
12. Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, et al. Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997; 314:272-276.
13. Ekbom T, Dahlof B, Hansson L, Lindholm LH, Oden A, Schersten B, Wester PO. The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure - Insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Blood Press 1992; 1:168-172.
14. Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet 2001; 358:2130-2131.
15. Trilling JS, Froom J. The urgent need to improve hypertension care. Arch Fam Med 2000; 9:794-801.
16. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95:1085-1090.
17. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions. J Hypertens 2001; 19:335-341.
18. Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E. Antihypertensive pharmacogenetics: Getting the right drug into the right patient. J Hypertens Suppl 2001; 19:1-11.